Barostim and the Window of Opportunity in Class II/III HFrEF Patients THT 2024 Discussion

0 views
April 24, 2024

Hear discussion and insights from Drs. J. Thomas Heywood, JoAnn Lindenfeld, Gurusher Panjrath, and Dmitry Yaranov following the THT 2024 symposium.

Comments 0
Login to view comments. Click here to Login